Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice

Sean Z. Zhao, MD, PhD;Thomas A. Burke, PharmD, MPH;Andrew Whelton, MD, PhD;Heather von Allmen;Scott C. Henderson, MS;

Publication

Article

October 1, 2002

Supplements and Featured Publications

Cardiorenal Differences Among NSAIDs and Coxibs: Real-World Experience

Volume8

Issue 15 Suppl

Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice

Author(s):

Sean Z. Zhao, MD, PhD,Thomas A. Burke, PharmD, MPH

Download PDF: Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions

Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice

Newsletter